Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ACADIA announces top-line results from phase 3 schizophrenia trial of Pimavanserin
Image: ACADIA announces top-line results from phase 3 schizophrenia trial of Pimavanserin. Photo: courtesy of Belova59 from Pixabay.
Image: ACADIA announces top-line results from phase 3 schizophrenia trial of Pimavanserin. Photo: courtesy of Belova59 from Pixabay.